P. M. SAİP, "Nine versus52 weeks of adjuvant trastuzumab in early breast cancer:An observational study of the Turkısh Oncology Group," JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.15, Alexandrıa, United States Of America, pp.629, 2011
SAİP, P. M. 2011. Nine versus52 weeks of adjuvant trastuzumab in early breast cancer:An observational study of the Turkısh Oncology Group. JOURNAL OF CLINICAL ONCOLOGY , (Alexandrıa, United States Of America), 629.
SAİP, P. M., (2011). Nine versus52 weeks of adjuvant trastuzumab in early breast cancer:An observational study of the Turkısh Oncology Group . JOURNAL OF CLINICAL ONCOLOGY (pp.629). Alexandrıa, United States Of America
SAİP, Pınar. "Nine versus52 weeks of adjuvant trastuzumab in early breast cancer:An observational study of the Turkısh Oncology Group," JOURNAL OF CLINICAL ONCOLOGY, Alexandrıa, United States Of America, 2011
SAİP, Pınar M. . "Nine versus52 weeks of adjuvant trastuzumab in early breast cancer:An observational study of the Turkısh Oncology Group." JOURNAL OF CLINICAL ONCOLOGY , Alexandrıa, United States Of America, pp.629, 2011
SAİP, P. M. (2011) . "Nine versus52 weeks of adjuvant trastuzumab in early breast cancer:An observational study of the Turkısh Oncology Group." JOURNAL OF CLINICAL ONCOLOGY , Alexandrıa, United States Of America, p.629.
@conferencepaper{conferencepaper, author={Pınar Mualla SAİP}, title={Nine versus52 weeks of adjuvant trastuzumab in early breast cancer:An observational study of the Turkısh Oncology Group}, congress name={JOURNAL OF CLINICAL ONCOLOGY}, city={Alexandrıa}, country={United States Of America}, year={2011}, pages={629} }